A novel intramuscular bivalent norovirus virus-like particle vaccine candidate--reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adults.
about
Tropical and travel-associated norovirus: current conceptsVaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio choleraeNorovirus immunology: Of mice and mechanismsAntiviral targets of human norovirusesB-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine.Intranasal delivery of a bivalent norovirus vaccine formulated in an in situ gelling dry powder.Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trialGenotype considerations for virus-like particle-based bivalent norovirus vaccine composition.Repurposing of rutin for the inhibition of norovirus replication.Virus Genotype Distribution and Virus Burden in Children and Adults Hospitalized for Norovirus Gastroenteritis, 2012-2014, Hong Kong.Serum Immunoglobulin A Cross-Strain Blockade of Human NorovirusesCombination vaccines against diarrheal diseases.Serological Correlates of Protection against a GII.4 Norovirus.Correlates of Protection against Norovirus Infection and Disease-Where Are We Now, Where Do We Go?Innate Resistance and Susceptibility to Norovirus InfectionNorovirus Epidemiology in Africa: A Review.Modelling Estimates of Norovirus Disease in Patients with Chronic Medical Conditions.Complicated norovirus infection and assessment of severity by a modified Vesikari disease score system in hospitalized children.Static and Evolving Norovirus Genotypes: Implications for Epidemiology and Immunity.Norovirus vaccines and potential antinorovirus drugs: recent advances and future perspectivesBurden of norovirus in healthcare facilities and strategies for outbreak control.Host Genetic Susceptibility to Enteric Viruses: A Systematic Review and Metaanalysis.Preclinical dose-ranging studies of a novel dry powder norovirus vaccine formulationMucosal and Cellular Immune Responses to Norwalk Virus.Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine.Norovirus vaccines: Correlates of protection, challenges and limitationsStructural basis for norovirus neutralization by an HBGA blocking human IgA antibodyImpact of Pre-exposure History and Host Genetics on Antibody Avidity Following Norovirus Vaccination.Thermal Inactivation of Foodborne Enteric Viruses and Their Viral Surrogates in Foods.Molecular epidemiology of norovirus in children and the elderly in Atlanta, Georgia, United States.Therapeutics and Immunoprophylaxis Against Noroviruses and Rotaviruses: The Past, Present, and Future.Prospects and Challenges in the Development of a Norovirus Vaccine.Molecular analysis of norovirus in specimens from children enrolled in a 1982-1986 study in Belém, Brazil: A community-based longitudinal study.Molecular analysis of norovirus in specimens from children enrolled in a 1982-1986 study in Belém, Brazil: A community-based longitudinal study.Targeting pediatric versus elderly populations for norovirus vaccines: a model-based analysis of mass vaccination options.Rapid Responses to 2 Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: A Randomized Controlled Trial.Assessment of Functional Norovirus Antibody Responses by Blocking Assay in Mice.Norovirus: new developments and implications for travelers' diarrhea.Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults.Emergence of Novel Human Norovirus GII.17 Strains Correlates with Changes in Blockade Antibody Epitopes.
P2860
Q26799737-54142F66-1990-46D7-B433-218DC7E2AF5AQ27004488-0D148A97-0E7F-4F46-8333-0C64E35DF525Q28083087-8B7DF56E-11C8-4185-9FAA-5C068ABAE5C8Q30249527-B6B367F8-5FB7-4D6E-9FD9-17F1D61F64FDQ33654573-5CD88BDA-2A45-40E6-88E4-815E1231763DQ33703664-0B40DA24-52E0-4C5E-8037-3D8672895651Q35212408-A9EBDA02-CDED-406D-9A9A-242C67862C51Q35656636-C259A97E-AD05-4056-B278-65CDFB6B8CB6Q35674963-F763054B-E50A-4807-B685-A7BD9DA045B9Q35749942-ACEA7E30-BADA-4FA1-8EA2-586CEAC95286Q35837799-C9BA6822-CF2B-4996-B8C8-4E57290B7202Q35896237-AD86F368-6A36-47EA-8268-884928E7B125Q35901978-548721EE-B533-4AD8-A2DB-EC582FB36DD9Q35999334-D017A82C-BB51-4E62-8128-380112D1694FQ35999366-BF2FE8A1-6FCD-4F8F-BFD0-7B8DC41E9B3AQ35999812-49FB4B0C-2D7F-44C7-9ECA-782B3CBC1B61Q36082874-C8EB4535-6DA0-4AB0-924C-AB99963F9814Q36157186-5ABAC44C-BCC2-40A4-AC25-EAB33C7FE7C0Q36254157-92D21541-75FC-4425-9AAA-86969FF3C39FQ36275589-BE1565F9-B2F7-41D7-8681-077F4E7BCF39Q36344240-C0ED9E75-E7B3-44B4-A978-0D6C79799F5EQ36373327-4B82BCFF-9773-4BCB-94DD-923ED9310CAFQ36642590-92EBB928-5409-4603-B62F-053185E652E6Q36756413-8C055F73-27A3-4145-9E1C-910091DB5933Q37135255-7DDA7EDF-2436-4E41-A7F9-28F1081CA3C5Q37135476-5474E49C-7B33-470D-8CC9-76E4725A9B24Q37323139-61A48C4F-518B-45C2-93D1-874B656DA370Q38374766-3DC3865E-A72C-449C-B9E7-88A33D2571F9Q38556232-1A110022-9C60-4EC3-B7BF-D476836C2A01Q38645513-7FE57CFA-0E36-413B-B090-0BBD68237AB2Q40044140-9F917C03-3E3F-4819-BC45-134B5BC20CC2Q40102851-4B4D96E7-8A57-4BC4-A06F-81D18BD93D84Q40261280-048AD7B4-3985-4CF2-B8FB-B6A9C1FD5131Q40283651-C7B80F98-288A-4F15-B353-B5DEB237EA56Q40485965-6EC2FA10-7D39-44B9-B5B4-527B1020C40CQ40632645-6CB98960-FF1F-4F23-970E-FA46F9C8493BQ40715789-E0DA4A05-33EE-413F-A010-B4F861848B46Q40988466-B32D91A6-B674-422C-927E-920C1941D771Q41743964-C385C33D-E50E-4338-AAF6-BBD914CB87A2Q41925431-7372E8F3-E444-44E0-946A-5719889C6C98
P2860
A novel intramuscular bivalent norovirus virus-like particle vaccine candidate--reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adults.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
A novel intramuscular bivalent ...... ase 1 trial in healthy adults.
@en
type
label
A novel intramuscular bivalent ...... ase 1 trial in healthy adults.
@en
prefLabel
A novel intramuscular bivalent ...... ase 1 trial in healthy adults.
@en
P2093
P356
P1476
A novel intramuscular bivalent ...... ase 1 trial in healthy adults.
@en
P2093
Astrid Borkowski
Jennifer Ferreira
John J Treanor
Paul M Mendelman
Ralf Clemens
Robert Goodwin
Robert Gormley
Sharon E Frey
Wilbur H Chen
P304
P356
10.1093/INFDIS/JIU337
P407
P577
2014-06-20T00:00:00Z